Company Overview and News

60
Have Analysts Become Too Bearish on Costco Stock?

10h investorplace
Since mid-April, Costco Wholesale Corporation (NASDAQ:COST) stock has had quite a run. COST stock was somewhat choppy in 2017, but 2018 has been a different story. Costco stock has gained 25% so far this year, and nearly all of the gains have come over the last five months.
WFC WFCNP COST WMT TGT V KR AMZN

7
Visa Inc. (V) Management Presents at Autonomous Research Future of Commerce Symposium Conference (Transcript)

12h seekingalpha
Visa Inc. (NYSE:V) Autonomous Research Future of Commerce Symposium Conference Call September 20, 2018 9:50 AM ET
V

48
What sector overhaul means for tech stocks, Wall Street

2018-09-19 malaymail
NEW YORK, Sept 20 ― The most significant changes to Wall Street's broad industry sectors since 1999 will take effect Monday, reclassifying many of the hot growth companies that have been nearly synonymous with the “tech” rally that has fuelled the stock bull market.
FB EA CCV CMCSA CTL NFLX CCZ PYPL GOOG ATVI VZA V GOOGL CCV.CL TWTR AAPL VZ CSCO MSFT INTC CMCSK CSCOI DIS

9
This Is What Disruption Looks Like: The Coming Shakeout In Transaction Banking

2018-09-19 seekingalpha
All kinds of banks (global banks, local banks, investment banks) could be piling into the transaction banking business.
V MA

48
What sector overhaul means for tech stocks, Wall Street

2018-09-19 channelnewsasia
The most significant changes to Wall Street's broad industry sectors since 1999 will take effect Monday, reclassifying many of the hot growth companies that have been nearly synonymous with the "tech" rally that has fueled the stock bull market.
FB EA CCV CMCSA CTL NFLX CCZ PYPL GOOG ATVI VZA V GOOGL CCV.CL TWTR AAPL VZ CSCO MSFT INTC CMCSK CSCOI DIS

48
What sector overhaul means for tech stocks, Wall Street

2018-09-19 reuters
NEW YORK (Reuters) - The most significant changes to Wall Street’s broad industry sectors since 1999 will take effect Monday, reclassifying many of the hot growth companies that have been nearly synonymous with the “tech” rally that has fueled the stock bull market.
FB EA CCV CMCSA CTL NFLX CCZ PYPL GOOG ATVI VZA V GOOGL CCV.CL TWTR AAPL VZ CSCO MSFT INTC CMCSK CSCOI DIS

20
Crash Protection For Square

2018-09-19 seekingalpha
Square was one of the top 10 names I shared with subscribers in February; over the next 6 months, it was up nearly 80%.
V SQ TWTR AAPL

7
Is Visa Going To Raise Its Dividend For A Second Time This Year?

2018-09-19 seekingalpha
Since its IPO in 2008, Visa (V) has been raising its dividend in October every year. However, the company raised its dividend in March this year, at a lackluster 7.7% rate. As its shareholders have got used to double-digit dividend growth rates, the big question is whether Visa will announce another dividend hike next month.
V

14
Visa (V), Mastercard to Settle U.S. Merchant Litigation

2018-09-19 zacks
Visa Inc. (V - Free Report) , Mastercard Incorporated (MA - Free Report) , along with banks including JPMorgan Chase & Co. (JPM - Free Report) , Citigroup Inc. (C - Free Report) and Bank of America Corp. would pay merchants about $6.5 billion on account of Payment Card Interchange Fee and Merchant Discount Antitrust Litigation.
C UNP MA V CGBBW

19
Wall Street rebounds in the face of heated trade row

2018-09-19 thehindubusinessline
Apple Inc shares were up 0.7 per cent after Chief Executive Tim Cook expressed optimism that the US-China trade dispute will be amicably settled.
GIS FIT V NKE BOE AAPL MA BA

67
15 Best S&P 500 Stocks to Buy as the Markets Heat Up

2018-09-19 investorplace - 1
One of the more popular strategies among investors today is to seek out “home runs.” These are lesser-known companies that have tremendous upside potential, but carry the risk of collapsing should business prospects go awry. While a balanced portfolio allows for some speculation, now is also a great time to consider S&P 500 stocks.
LMT HD EA FB UPS MA DRI FDX BBY HOG GT V AMZN CVX RTN ABBV HPQ MO

19
Wall Street rebounds in the face of heated trade row

2018-09-18 reuters
NEW YORK (Reuters) - Wall Street bounced back on Tuesday, led by gains in consumer discretionary, technology and industrial stocks as investors shrugged off escalating trade rhetoric between the United States and China.
GIS FIT V NKE BOE AAPL MA BA

21
Visa, Mastercard reach $6.2 billion settlement on swipe fees

2018-09-18 thestar
This copy is for your personal non-commercial use only. To order presentation-ready copies of Toronto Star content for distribution to colleagues, clients or customers, or inquire about permissions/licensing, please go to: www.TorontoStarReprints.com
C MA V CGBBW SBUX

15
Visa, Mastercard reach US$6.2b settlement over card-swipe fees

2018-09-18 theedgemarkets
NEW YORK (Sept 18): Visa Inc, Mastercard Inc, and a number of US banks on Tuesday agreed to pay US$6.2 billion to settle a long-running lawsuit brought by merchants over the fees they pay when they accept card payments.
V COST MA

8
Micron Call Options May Be Underpriced

2018-09-18 seekingalpha
Management announced a $10 billion buyback in May for FY 2019, which could start as soon as September 24th.
V AAPL

Related Articles

RIGL: Rigel Pharmaceuticals Analysis and Research Report

2018-09-18 - Asif

Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...

EKSO: Ekso Bionics Holdings Analysis and Research Report

2018-09-18 - Asif

Overview The company design, develop and sell exoskeleton technology to augment human strength, endurance and mobility. The company's exoskeleton technology serves multiple markets and can be used both by able-bodied users as well as by persons with physical disabilities. Ekso Bionics has sold, rented or leased devices that (a) enable individuals with neurological conditions affecting gait (stroke and spinal cord injury) to rehabilitate and to walk again and (b) allow industrial workers to perform heavy duty work for extended periods. Today, its medical exoskeleton, Ekso GT, is used as a rehabilitation tool to allow physicians and therapists to rehabilitate patients who have suffered a stroke or spinal cord injury. With its unique features designed specifically for hospitals and its proprietary SmartAssist software, Ekso GT allows for the early mobilization of patients, with high step count and high dosage treatments. The intent is to allow the patient’s central nervous syst...

AGRX: Agile Therapeutics Analysis and Research Report

2018-09-18 - Asif

Overview Agile Therapeutics is a forward-thinking women’s healthcare company dedicated to fulfilling the unmet health needs of today’s women. Twirla® and its other current potential product candidates are designed to provide women with contraceptive options that offer greater convenience and facilitate compliance. The company's lead product candidate, Twirla, also known as AG200-15, is a once-weekly prescription contraceptive patch that is at the end of Phase 3 clinical development. Since its inception in 1997, Agile Therapeutics has devoted substantial resources to developing Twirla, building its intellectual property portfolio, business planning, raising capital and providing general and administrative support for these operations. The company incurred research and development expenses of $14.4 million, $20.9 million and $25.6 million during the years ended December 31, 2017, 2016 and 2015, respectively. The company incurred research and development expenses of $2.4 milli...

Silicon Investor Message Boards

This table lists all message boards related to V / Visa, Inc. on message board site Silicon Investor.

Formerly About Advanced Micro Devices Formerly About Advanced Micro Devices Formerly About Advanced Micro Devices Tesla EVs - TSLA Tesla EVs - TSLA Tesla EVs - TSLA
AMD, ARMH, INTC, NVDA AMD, ARMH, INTC, NVDA AMD, ARMH, INTC, NVDA Da_cheifs vomitorium Da_cheifs vomitorium Da_cheifs vomitorium
View from the Center and Left View from the Center and Left View from the Center and Left Liberalism: Do You Agree Weu0027ve Had Enough of It? Liberalism: Do You Agree Weu0027ve Had Enough of It? Liberalism: Do You Agree Weu0027ve Had Enough of It?
Income Investing Income Investing Income Investing Buy and Sell Signals, and Other Market Perspectives Buy and Sell Signals, and Other Market Perspectives Buy and Sell Signals, and Other Market Perspectives
OLED Universal Display Corp OLED Universal Display Corp OLED Universal Display Corp Off Topic (Every Day Technology) Off Topic (Every Day Technology) Off Topic (Every Day Technology)
CUSIP: 92826C839